P543: TARGETING SAMHD1 WITH HYDROXYUREA IN FIRST-LINE CYTARABINE-BASED THERAPY OF NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE HEAT-AML TRIAL

P543: TARGETING SAMHD1 WITH HYDROXYUREA IN FIRST-LINE CYTARABINE-BASED THERAPY OF NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE HEAT-AML TRIAL

Bibliographic Details
Main Authors: M. Jädersten, I. Lilienthal, N. Tsesmetzis, M. Lourda, S. Bengtzén, A. Bohlin, C. Arnroth, T. Erkers, B. Seashore-Ludlow, G. Giraud, G. S. Barkhordar, S. Tao, L. Fogelstrand, L. Saft, P. Östling, R. Schinazi, B. Kim, T. Schaller, G. Juliusson, S. Deneberg, S. Lehmann, G. Rassidakis, M. Höglund, J.-I. Henter, N. Herold
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000845060.66757.5c

Similar Items

Similar Items